Skip to Content


In the US, Decitabine (decitabine systemic) is a member of the drug class antimetabolites and is used to treat Acute Myeloid Leukemia and Myelodysplastic Syndrome.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Cytostatic agent: Antimetabolite

Chemical Names

1,3,5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-beta-D-erytro-pentofuranosyl)- (USAN)

4-Amino-1-(2-deoxy-beta-D-erytro-pentofuranosyl)-s-triazin-2(1H)-one (WHO)

4-amino-1-(2-desoxy-beta-D-erytro-pentofuranosyl)-s-triazin-2(1H)-on (IUPAC)



s-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-beta-D-erytro-pentofuranosyl)-

Foreign Names

  • Decitabinum (Latin)
  • Decitabin (German)
  • Decitabine (French)
  • Decitabina (Spanish)

Generic Names

  • Decitabine (OS: BAN, USAN)
  • 5-azaCdR (IS)
  • 5-aza-DCyd (IS)
  • d-AZc (IS)
  • Dezocitidine (IS)
  • NSC-127716 (IS: Pharmachemie)

Brand Names

  • Dacogen
    Eisai, United States; Janssen, Brazil; Janssen, Chile; Janssen, Finland; Janssen, Ireland; Janssen, Malaysia; Janssen, Norway; Janssen, Philippines; Janssen, Romania; Janssen, Sweden; Janssen, Thailand; Janssen Cilag, Argentina; Janssen Pharmaceutica, Slovenia; Janssen-Cilag, Belgium; Janssen-Cilag, Switzerland; Janssen-Cilag, Colombia; Janssen-Cilag, Germany; Janssen-Cilag, Denmark; Janssen-Cilag, France; Janssen-Cilag, United Kingdom; Janssen-Cilag, Israel; Janssen-Cilag, Italy; Janssen-Cilag, Lithuania; Janssen-Cilag, Poland; Janssen-Cilag International, Cyprus; Janssen-Cilag Pharma, Austria; Johnson & Johnson, Turkey
  • Detavi
    Dosa, Argentina


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.